Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project-Reference-Cited by-同舟云学术

Multi-centre, multi-database studies with common protocols: lessons learnt from the IMI PROTECT project

Published:2016-03 Issue: Volume:25 Page:156-165
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Klungel Olaf H.¹²,Kurz Xavier³,de Groot Mark C. H.¹⁴,Schlienger Raymond G.⁵,Tcherny-Lessenot Stephanie⁶,Grimaldi Lamiae⁷,Ibáñez Luisa⁸,Groenwold Rolf H. H.¹²,Reynolds Robert F.⁹

Affiliation:

1. Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht University; Utrecht the Netherlands

2. Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht (UMCU); Utrecht the Netherlands

3. European Medicines Agency (EMA); London United Kingdom

4. Department of Clinical Chemistry and Haematology, Division of Laboratory and Pharmacy; University Medical Center Utrecht; Utrecht the Netherlands

5. Quantitative Safety and Epidemiology, Novartis Pharma AG; Basel Switzerland

6. Global Pharmacovigilance and Epidemiology; Sanofi Chilly-Mazarin France

7. LA-SER and Pasteur Institute (Pharmacoepidemiology and Infectious Diseases Unit); Paris France

8. Fundació Institut Català de Farmacologia (FICF); Barcelona Spain

9. Epidemiology; Pfizer; New York NY USA

Funder

Innovative Medicines Initiative Joint Undertaking (IMI JU)

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference36 articles.

1. Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project;Abbing-Karahagopian;Curr Clin Pharmacol,2014

2. Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership;Stang;Ann Intern Med,2010

3. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction;Platt;Pharmacoepidemiol Drug Saf,2012

4. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?;Trifirò;Pharmacoepidemiol Drug Saf,2009

5. The risk of acute liver injury among users of antibiotic medications: a comparison of case-only studies;Brauer;Pharmacoepidemiol Drug Saf,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review;Pharmacoepidemiology and Drug Safety;2024-05

2. Principles of Pharmacovigilance and Drug Regulation;Principles and Practice of Pharmacovigilance and Drug Safety;2024

3. Applying Machine Learning in Distributed Data Networks for Pharmacoepidemiologic and Pharmacovigilance Studies: Opportunities, Challenges, and Considerations;Drug Safety;2022-05

4. Transformation and Evaluation of the MIMIC Database in the OMOP Common Data Model: Development and Usability Study;JMIR Medical Informatics;2021-12-14

5. Views from Academia, Industry, Regulatory Agencies, and the Legal System;Textbook of Pharmacoepidemiology;2021-11-15